As CXCL5 has been previously linked to recruitment of suppressive immune cell phenotypes36, metastatic processes37–39 and also shown to be under circadian gating35,40 we assessed its receptor, CXCR2 level in primary tumours. The gene discussed is CXCR2; the disease is neoplasm.